Suprachoroidal Delivery – A Novel Approach

Time: 2:30 pm
day: Day One


  • Potential advantages of suprachoroidal delivery include targeting of affected chorioretinal tissues for potential efficacy benefits, compartmentalization away from unaffected tissues for potential safety benefits, and bioavailability
  • Durability for small molecule suspensions is driven by its relative insolubility and particle size
  • Multiple classes of therapeutic agents are being assessed suprachoroidally in clinical trials globally, including a corticosteroid, tyrosine kinase inhibitor, gene therapy, and virus-like drug conjugates